26 january 2023
First webinar for veterinarians in cooperation with Dr. E. Graeub AG: a great success!
On 15.12.22 the first cold plasma training for vets took place as a webinar in cooperation with Dr. E. Graeub AG. Together with Dr. med. vet. Dipl. ACVD & EBVS Claudia Nett, the Vet-Team of the ActivCell Group made a highly professional contribution to the further promotion of cold plasma in the veterinary profession. Almost 200 registrations from interested veterinarians prove this impressively. The basic principles of cold plasma therapy and its possible applications in dermatology and wound healing were presented. The webinar is saved and can be viewed on request.
13 January 2023
Dr Dominik Lysek joins the Board of Directors of ActivCell Group AG
Dominik Lysek is a trained chemist with a Master’s degree from The University of Edinburgh and a PhD from the ETH Zurich.
After working at Geistlich Pharma and Auris Medical in the field of clinical research, he founded the medical technology company Credentis in 2010. As CEO, Dominik Lysek was, among others, responsible for the clinical program of Credentis, which developed innovative products for dentistry and oral hygiene. Since the successful sale of the company in 2020 to vVardis, where he is still employed as Co-Chief Scientific Officer, Dominik Lysek has taken on various roles at innovative companies in the medical technology and pharmaceutical industries.
With his background in clinical affairs, his experience in medical technology and his large network in the MedTech environment, Dominik Lysek will actively help to shape the strategic direction of ActivCell Group AG.
Dominik Lysek was unanimously elected to the Board of Directors of ActivCell Group AG at the Annual General Meeting on 27 June 2022. The three existing members of the Board of Directors, with Ruedi Weber as Chairman, were confirmed in office.
8 August 2022
New to the team: Dr Stephan Gregorini
After completing his state examinations in food chemistry at the Technical University of Berlin, Stephan Gregorini worked scientifically at various German research institutions.
He obtained his PhD at the Institute of Biogeochemistry and Marine Chemistry at the University of Hamburg and in parallel completed further trainings in toxicology and ecotoxicology.
Stephan Gregorini began his professional career at Ecolab and then moved to Lonza as a Regulatory Affairs Specialist, where he assumed the position of Senior Manager, Head of Regulatory Affairs EMEA Hygiene, Homecare & Personal Care after only three years, and most recently also held this position at Arxada.
We are pleased to have Stephan Gregorini on board of ActivCell Group AG as Senior Manager Regulatory Affairs & Quality Management.
22 July 2022
Dr Dominik Lysek joins the Board of Directors of ActivCell Group AG
Dominik Lysek is a trained chemist with a Master’s degree from The University of Edinburgh and a PhD from the ETH Zurich.
After working at Geistlich Pharma and Auris Medical in the field of clinical research, he founded the medical technology company Credentis in 2010. As CEO, Dominik Lysek was, among others, responsible for the clinical program of Credentis, which developed innovative products for dentistry and oral hygiene. Since the successful sale of the company in 2020 to vVardis, where he is still employed as Co-Chief Scientific Officer, Dominik Lysek has taken on various roles at innovative companies in the medical technology and pharmaceutical industries.
With his background in clinical affairs, his experience in medical technology and his large network in the MedTech environment, Dominik Lysek will actively help to shape the strategic direction of ActivCell Group AG.
Dominik Lysek was unanimously elected to the Board of Directors of ActivCell Group AG at the Annual General Meeting on 27 June 2022. The three existing members of the Board of Directors, with Ruedi Weber as Chairman, were confirmed in office.
19 July 2022
Milana Becic takes over the administration of the Lenzburg office
A breath of fresh air in our office: Milana Becic took over the administration of the ActivCell Group AG office in Lenzburg on 20 June 2022.
After her commercial apprenticeship at Alu Menziken AG, Milana Becic completed the commercial vocational baccalaureate at AKAD while already working. This was followed by various positions at Taff Tool AG, ReCare AG and migrolino in sales support and administration.
Milana brings practical experience in the preparation of quotes and order processing, in event organisation and general administrative activities and will support the ActivCell Group team.
23 June 2022
ActivCell Group AG in Cologne:
Review of the successful first participation in the ‘Deutsche Vet’:
Together with the distribution partner for Germany and the Czech Republic – MD Innovation Tech GmbH – our Veterinary Division was able to present the EquCellpen® and the PetCellpen® for the first time at the ‘Deutsche Vet’ from June 10 to 11, 2022 in Cologne.
The lively exchange with numerous veterinarians at the ActivCell Group AG booth showed that cold plasma therapy is becoming increasingly well-known in veterinary medicine. Accordingly, an increase in sales to Germany was recorded, which rounded off the successful congress appearance.
7 June 2022
New distribution platform for veterinary products in Benelux and Denmark: Lytje
Lytje, the newly created sales platform specifically for ActivCell Group’s veterinary products, is targeted at potential customers in the Benelux countries and Denmark. This platform is operated by ASmax in Brüggen. With the new distribution partner ASmax, we will have an experienced cold plasma marketer at our side who will distribute the PetCellPen® as well as the EquCellPen® in Belgium-Netherlands-Luxembourg and Denmark from June 2022. This opens up several additional markets for us within the EU.
19 May 2022
ActivCell Group AG in Paris:
Joint EWMA und Journées Cicatrisations Conference
After several corona-related virtual events, this year’s EWMA conference finally takes place live again, together with the Journées Cicatrisations of the French Wound Healing Society SFFPC.
The ActivCell Group AG will be exhibiting at the joint EWMA and Journées Cicatrisations conference from May 23-25, 2022 in Paris.
27 April 2022
ActivCell Group AG at the 16th German Wound Congress in Bremen
After two years of pandemic, now live again: The German Wound Congress DEWU is the largest German forum on the topic of chronic wounds with around 4300 specialist participants at the last event and will take place in Bremen from 4-6 May 2022.
ActivCell Group AG will participate in this 16th German Wound Congress DEWU as an industrial exhibitor.
15 December 2021
Veterinary Division: Dr. med. vet. Selina Keller
new Product & Sales Manager
Dr. med. vet. Selina Keller completed her doctorate in bacteriology at the University of Zurich after passing her state examination in veterinary medicine. As an assistant veterinarian at the Institute for Veterinary Bacteriology at the University of Zurich and at the Centre for Laboratory Medicine in St. Gallen, she was able to further expand her knowledge in veterinary diagnostics. She then spent further years as an assistant veterinarian in various veterinary practices in Switzerland, where she was able to gain extensive practical experience in both large animal and small animal practice.
– Curriculum Dr. Selina Keller (PDF)
Dr Keller can now bring her scientific background combined with her knowledge of the needs of veterinary practice to our team. She supports the Veterinary Division of the ActivCell Group in advising and training distribution partners and veterinarians. In addition, she will play an important role in the cooperation with our study partners and universities.
16 November 2021
Exclusive sales partner for the veterinary sector in Austria: Richter Pharma, Wells
The traditional pharmacy on ‘Stadtplatz’ was founded in Wels as early as 1600 and has since developed into a globally successful pharmaceutical company. Richter Pharma has been owned by the Richter/Fritsch families for over 100 years. The company has succeeded in maintaining its proximity to customers despite its growth. The introduction of new products into the medical market is a strategic focus of the company.
As the leading supplier of veterinarians in Austria, Richter is the ideal distribution partner for veterinary products. Richter Pharma will exclusively sell the device lines of ActivCell Group AG for veterinary medicine in Austria from November 2021.
28 October 2021
ActivCell Group AG at the 20th Symposium on Modern Wound Treatment of the SAfW at Technopark Zurich
The Swiss Society for Wound Treatment SAfW aims to research, develop, promote and disseminate procedures for wound treatment.
In particular, it aims to educate and advise professionals and the general public about the possibilities of active and preventive measures in the context of wound treatment.
ActivCell Group AG participates as an exhibitor in the 20th Symposium on Modern Wound Treatment of the SAfW on 11 November 2021 at Technopark Zurich.
15 September 2021
Exclusive sales partner for the veterinary sector in Germany and the Czech Republic:
MD Innovation Tech GmbH, Arzberg
The German company MD Innovation Tech GmbH, based in Arzberg, focuses on the sale of high technology for medical research and clinic for both human and veterinary medicine. The particular strength of this company lies in the market introduction of innovative medical technology. MD employs 10 highly qualified sales experts with profound knowledge (medicine, physics, technology), who maintain contact with research institutes, universities as well as clinics.
MD Innovation Tech GmbH will exclusively sell the device lines of ActivCell Group AG for veterinary medicine in Germany and the Czech Republic from September 2021.
2 September 2021
ActivCell Group AG at the 35th International Wound Management Congress organized by the Akademie ZWM in Salzburg
The Akademie-ZWM® AG is an independent advisory and training institution in the field of wound treatment and a pioneer in education and training in wound management.
The goal of the Akademie ZWM is to educate and advise nursing staff and doctors, and also to make the general public aware of the possibilities of active and preventive measures in wound treatment through informative events and continuous training.
ActivCell Group AG will participate as an industry partner in the 35th International Wound Management Congress organized by the Academy ZWM® from 9-11 September 2021 in Salzburg.
1 September 2021
Dr med. vet. Dipl. ACVD & EBVS® Claudia Nett, joins the Veterinary Advisory Board
Dr Claudia Nett holds the internationally recognised specialist titles of the American (ACVD) and the European College of Veterinary Dermatology (ESVD). The founder and owner of veterderm.ch – Dermatology and allergology for animals works as a specialised veterinary surgeon for the Ennetseeklinik in Hünenberg and in the small animal practice Schwäntenmos in Zumikon. Claudia Nett speaks regularly at national and international congresses. She is President of the Swiss Association of Small Animal Medicine (SVK) and Founding President and Vice President of the Swiss Association of Veterinary Dermatology (SAVD) and Past President of the European Society of Veterinary Dermatology (ESVD).
– Curriculum Dr Claudia Nett (PDF)
Dr Claudia Nett has joined the Veterinary Advisory Board as of August 2021, replacing Dr Silvia Rüfenacht. In addition to her extensive expert knowledge, she brings several years of practical experience with cold plasma therapy in small animal dermatology. With her activities on the boards of national and international professional associations, Dr Nett facilitates contact with important personalities from research and clinical practice. With this collaboration, the ActivCell Group is taking another important step towards becoming a ‘Swiss centre of excellence for plasma medicine’. Dr Silvia Rüfenacht will continue to work with ActivCell on research into the possible uses of cold plasma in veterinary dermatology.
6 July 2021
New case studies from veterinary medicine
Numerous studies from human medicine prove the evidence of cold plasma therapy. Comparable treatment successes can also be expected in veterinary medicine. It is important for veterinarians and therapists to know for which indications plasma is a promising therapy option to treat animals. Since extensive clinical studies take time, case studies can be informative in advance. ActivCell documents feedback from the clinic and makes information available to the professional community. Feedback from specialists is particularly important.
Astonishing are cases from the equine clinic of Mrs Verena Bracher, PhD, Dr. med. vet. (Member of Veterinary Advisory Board, ActivCell) which show how cold plasma therapy as the ‘last resort’ can heal. There is the case of a foal with therapy-resistant purulent bursitis at the hock joint, which did not want to heal even after two surgical interventions and antibiotic therapy. A total loss of the valuable foal was threatened until the EquCellpen® came into use.
More case studies are available here:
– EquCellpen® case studies (in German, PDF)
– PetCellpen® case studies (in German, PDF)
14 May 2021
A breath of fresh air in the veterinary practice – cold plasma therapy using the PetCellpen® live on camera
(film in German)
ActivCell Group AG presents its informative application film on the use of the PetCellpen® in small animal practice, which was launched on the occasion of the virtual 8th Swiss Veterinary Days at the beginning of May 2021. It is now also available on the website.
The film clearly describes the properties and mode of action of cold plasma. Experts explain the fundamental mechanisms of action of cold plasma therapy.
Veterinarians have their say and show how the treatment is carried out and how their animal patients react to it.
For them, the PetCellpen® has become an indispensable part of their daily practice and Dr. med. vet. Nadja Iveta Meier sums up her experience with the words: “I think it’s absolutely phenomenal”.
21 April 2021
Daniele Scarabello: new Manager
Finance & Administration
After completing his basic education as a polytechnician, Daniele Scarabello graduated as an industrial engineer. He has been working for a start-up company since 2015, initially in production and logistics and for the last 3 ½ years as Head of Finance, Administration & HR. He is also a member of the Executive Committee and Executive Assistant to the Chairman of the Board of Directors.
In February 2021, Daniele Scarabello started a two-year master’s program in international management.
He has practical experience in Accounting & Controlling as well as in process optimization and logistics. In addition, he has completed a quality certification according to ISO 9001:2015. He is business fluent in German, English, French and Italian.
On April 1, 2021, Daniele Scarabello started at ActivCell Group AG as Manager Finance and Administration and will actively support the further development of the company.
6 April 2021
ActivCell Group AG becomes a member of the National Center of Plasma Medicine in Germany
The National Center for Plasma Medicine e.V. (NZPM) promotes research and development in the various fields of application of cold plasma therapy in Germany and beyond national borders.
With its commitment to the science-based development of this form of therapy in wound treatment as well as in other application areas, the ActivCell Group AG contributes to the spread and increasing implementation of plasma medicine as a therapeutic option in medical practice and has therefore joined the NZPM.
On March 26, 2021, ActivCell Group AG was welcomed as a member by the board of the NZPM and accepted into the association.
3 March 2021
Design protection for the devices of the ActivCell Group AG in Switzerland
ActivCell Group AG has reached another milestone: The design of the Cellpen series has been entered in the design register by the Swiss Federal Institute for Intellectual Property.
The entry in the Designs CH register was published on February 26, 2021 with the number 145798. The inclusion in the register demonstrates that the devices of the ActivCell Group are significantly different from existing designs.
15 October 2020
CH market launch of PetCellpen® and relaunch of EquCellpen® completed
The two cold plasma therapy devices for veterinary medicine are now available through the exclusive distribution partner for Switzerland: Medical Solution GmbH in Wil SG is a renowned contact and supplier of medical technology for veterinary companies in Switzerland and Liechtenstein and is known for its good service. The ActivCell Group AG team supports Medical Solution GmbH with its expertise in providing advice and information on all aspects of plasma medicine for veterinary professionals.
25 September 2020
ActivCellpen® and EquCellpen® tested as a medical plasma source according to DIN SPEC 91315.
DIN SPEC 91315 defines how the general requirements for medical plasma sources are to be tested. The ActivCellpen® and EquCellpen® have successfully passed all the prescribed chemical, physical and biological tests at the Leibniz Institute for Plasma Research and Technology e.V. (INP). The properties of the cold plasma produced were determined by the testing institute; in particular its antiseptic effect was confirmed.
14 August 2020
ActivCell AG becomes ActivCell Group AG
Various business units operate under the umbrella of the ActivCell Group, serving very different markets. It is preferable to separate the human medicine and the veterinary medicine sectors in the future due to their very different market demands and growth scenarios. Therefore, at the 5th Annual General Meeting of ActivCell AG, it was decided to change the name of the company to ActivCell Group AG. With this decision, the shareholders are supporting the Board of Directors’ progressive growth strategy.
1 August 2020
New to the team: Dr Andrea Preuss, Head of Medical Division and Member of the Executive Board
Andrea Preuss holds a doctorate in microbiology and has worked in various industry sectors during her professional career. After starting her career at Degussa as head of a microbiology laboratory, she worked for eight years in various roles at Ciba (now BASF), most recently building up the Medical Device Materials business unit there. This was followed by positions in the medical device industry, in infection control product development at B. Braun in Sempach and as Product Manager in the Medical Division of Borer Chemie in Zuchwil. For the last eight years, Dr Preuss worked at Lonza, first as Global Marketing Manager Healthcare and later as Head Global Marketing Hygiene/Disinfection. Most recently, she led a business development project there in the area of infection prevention.
29 May 2020
Competent and well-connected: the newly formed Veterinary Advisory Board
The members of ActiveCell Group AG’s Advisory Board have a broad knowledge and many years of practical experience in veterinary medicine.
With Dr Verena Denise Bracher, Dr Silvia Rüfenacht, Prof. Adrian Steiner, Dr FHV Heinz Willi Burkhardt und Dr Michael Hiestand, universities, hospitals and practices are equally represented.
Our focus areas of dermatology, bovine medicine (buiatrics), small animal and equine medicine are very well represented by the members of the Advisory Board.
9 March 2020
New to the team: Ursula Meier, Internal Sales and Admin
Ursula Meier is a qualified businesswoman with additional training in accounting and IT support. She has many years of experience in finance and controlling, IT support and administration in clinical environments. As an active horse owner, she has also attended additional training in horse husbandry, training and therapy. Ursula Meier speaks German, French, English and Italian.
1 March 2020
New CEO: Thomas Fünfschilling
Thomas Fünfschilling holds a degree in industrial engineering from the Swiss Federal Institute of Technology (ETH) and has over 15 years of experience in international marketing and sales at the management level in well-known industrial companies. He has a track record in strategy development and implementation, business development, the solutions business, project business and change management. He is the co-founder and owner of a medical technology start-up founded in 2018.
1 February 2020
New second branch in Lenzburg
Since the beginning of 2020, ActivCell AG has had a new branch at Wolfsackerstrasse 49 in Lenzburg. Workstations and meeting rooms are available there.